Thursday, June 1, 2023
HomeUncategorizedNew clues to men's cancer risk; exercise and chemotherapy; GSK against ranitidine

New clues to men's cancer risk; exercise and chemotherapy; GSK against ranitidine

New clues to why men are more likely to develop cancer than women. (US News & World Report)

Dutch oncologists and surgeons use titanium mandibles made from 3D images The first portrait of a mandibular implant head and neck cancer patient was performed. ( Netherlands Cancer Institute )

New recommendations to determine eligibility for lung cancer clinical trials could improve patients’ access to trials. (UT Southwestern, JAMA Oncology)

Targeting BCL-2 expression has shown promise to overcome resistance to CAR T-cell therapy in relapsed/refractory B-cell non-Hodgkin lymphoma. (Penn Medicine, Cancer Discovery)

Two NCI grants The study will investigate whether physical activity can reduce chemotherapy toxicity and increase its effectiveness. ( LSU Pennington Biomedical Research Center )

First CAR T cell therapy for multiple myeloma Bristol-Myers Squibb and 2seventy bio announced a randomized trial showing B-cell maturation antigen-targeted therapy idecabtagene viccleucel (Abecma) significantly improved progression-free survival compared with standard of care.

Daiichi Sankyo and AstraZeneca announce FDA approval of trastuzumab deruxtecan (Enhertu) for HER2 positive Resection/metastatic non-small cell lung cancer.

Smoking Cancer-related deaths in 2019 were associated with 2 million years of lost lives and $21 billion in lost income, according to a study by the American Cancer Society.

FDA Periodically Approves Capmatinib (Tabrecta) for the Treatment of Metastatic Non-Small Cells Associated with MET Exon 14 Skipping Lung cancer.

Bayer announces FDA approval of darolutamide (Nubeqa) plus docetaxel for the treatment of diversion

for ” Speculative comment,” GSK said in a statement, “GSK, the FDA, and the EMA [European Medicines Agency] have independently concluded that there is no evidence that ranitidine treatment is associated with cancer in patients. There is a causal relationship.”

  • Charles Bankhead is the Senior Editor for Oncology and also covers Urology, Dermatology and Ophthalmology. He joined MedPage today in 2007. focus on



    Please enter your comment!
    Please enter your name here


    Featured NEWS